欢迎来到 BellBrook Labs中国区代理商/公司/官网
全国咨询热线: 18995651644
联系我们

地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301

电话:18771997407

传真:15172431432

邮箱:sales@amyjet.com

新闻中心
TOKU-E.png

TOKU-E公司专注于体外抗生素生产技术,并快速成长为世界领先的超纯抗生素供应者,以低廉的价格提供最全面的超纯抗生素,其纯度大于99%,用于动物细胞培养、植物组织培养、微生物、抗真菌及诊断等科研领域,允许研究者提高抗生素浓度,并消除污染,降低对细胞的伤害,从而提高筛选效率;该公司还提供精细化学试剂,如超纯丙烯酰胺、无尘SDS、胍盐等,极大提高了实验的精确性和安全性,可满足生命科学研究领域各科研机构,标准化组织机构的高标准需求。

 

When our doors first opened in 1981, we were a chemical trading company in Tokyo, Japan called TOKUICHI, which means‘moral first’in Japanese. Having established a firm foundation, our company focused on manufacturing antibiotics through fermentation, then specialized in pharma and biotech research sectors. To reflect our growth into a leading global antibiotic manufacturer, we updated our name to TOKU-E. Though we have expanded our scope to better serve our customers, we still maintain our strong moral fiber.

TOKU-E has facilities in the US, China, Europe, and Singapore to serve you globally, and our network of worldwide distributors offers region-specific expertise. Our company is ISO 9001:2015 certified, for your regulatory peace of mind.

 

TOKU-E的主要产品包括:

(1)Cell Culture

Gene Selection Antibiotics

Contamination Control

Mycoplasma Detection & Elimination

(2)Cancer Research

Antitumor

Chemotherapeutics

Immunosuppressants

(3)Microbiology

Antimicrobials

Gene Selection Antibiotics

Beta-lactamase Inhibitors

Nitrocefin

Selective Agents

(4)Plant Biology

<

更多详情请联系 

艾美捷科技有限公司

全国服务热线:400-6800-868

邮箱:sales@amyjet.com

网站:www.amyjet.com

" data-original="http://bellbrook.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="TOKU-E">
TOKU-E
...
阅读详情
Imanislife logo .png

<

艾美捷科技代理Imanis Life Sciences品牌全系列产品


Imanis Life Sciences是一家专注于再生医学、基因治疗、肿瘤学及溶瘤病毒疗法研究领域的生物技术公司。Imanis Life Sciences科研领域提供两大核心解决方案:溶瘤病毒治疗研究产品:供应用于溶瘤病毒疗法研究的专用病毒制剂;非侵入性影像检测试剂:提供适用于体外及体内研究的全系列试剂,包括报告基因细胞系、报告基因慢病毒载体及特异性抗体。Imanis Life Sciences公司的产品主要包括高品质报告基因细胞系、慢病毒载体及基因构建体、NIS与VSV特异性抗体以及全系列溶瘤病毒资源库。


ImanisLifeSciences页面.png


▍Imanis Life Sciences产品线

● 报告基因慢病毒载体与质粒体系:提供全系列报告基因慢病毒载体及配套质粒解决方案。

即用型病毒载体:安全高效的即用颗粒,适用于原代细胞等难转染细胞类型的报告基因递送(无需额外处理);

病毒包装质粒系统:用于自主制备慢病毒载体颗粒的完整质粒体系。

● 稳定细胞系产品线:提供支持肿瘤学及免疫肿瘤学体内外研究的全系列稳定细胞系。

组成型报告基因细胞系(持续表达):搭载荧光素酶、荧光蛋白或NIS报告基因。应用于体外药物筛选 / 活体动物肿瘤动态监测

肿瘤抗原工程细胞系(靶标调控型):经基因编辑调控常见肿瘤相关抗原及治疗靶点表达水平,核心靶标:CD19、EGFR、Her2

● 溶瘤病毒资源库:提供涵盖即用型病毒储备的完整解决方案,全面助力溶瘤病毒疗法的体内外研究进程。

● 抗体:提供优质的NIS抗体产品,全面兼容免疫印迹(WB)、免疫组化(IHC)、免疫荧光(IF)、流式细胞术,同时推出多功能抗VSV(水泡性口炎病毒)抗体,覆盖WB/IHC/IF/ELISA/流式及VSV中和实验全平台。


▍Imanis Life Sciences部分产品列表


品名规格货号
V-pNIS0.25 mL;1.0 mLLV053S;LV053L
LV-Ub-humanNIS-P2A-Puro0.25 mL;1.0 mLLV038S;LV038L
LV-PGK-humanNIS-P2A-Puro0.25 mL;1.0 mLLV036S;LV036L
LV-humanNIS-P2A-Puro0.25 mL;1.0 mLLV019S;LV019L
LV-humanNIS-IRES-Neo0.25 mL;1.0 mLLV013S;LV013L
LV-humanNIS0.25 mL;1.0 mLLV001S;LV001L
LV-EF1α-humanNIS-P2A-Puro0.25 mL;1.0 mLLV037S;LV037L
LV-CAG-humanNIS-P2A-Puro0.25 mL;1.0 mLLV042S;LV042L
LV-rhesusNIS-PGK-Puro0.25 mL;1.0 mLLV018S;LV018L
LV-rhesusNIS0.25 mL;1.0 mLLV017S;LV017L
LV-EF1α-rhesusNIS-PGK-Puro0.25 mL;1.0 mLLV040S;LV040L
LV-mouseNIS-P2A-Neo0.25 mL;1.0 mLLV025S;LV025L
LV-mouseNIS-PGK-Puro0.25 mL;1.0 mLLV022S;LV022L
Anti-human NIS antibody SJ10.25 mlREA004
Monoclonal anti-human NIS antibody (affinity purified)100 ulREA011
Anti-human (KELE) NIS antibody (affinity purified)100 ulREA010
Anti-human (ETNL) NIS antibody (affinity purified)100 ulREA009
Anti-human NIS antibody clone VJ20.25mLREA003
Anti-human NIS antibody clone VJ10.25mLREA002
Anti-rat NIS antibody (affinity purified)100 ulREA008
Anti-VSV antibody0.25mLREA005



" data-original="http://bellbrook.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Imanis Life Sciences品牌全系列产品">
艾美捷科技代理Imanis Life Sciences品牌全系列产品
...
阅读详情

669f4e339c9f1.jpg


艾美捷科技代理深圳鼎升(AcroGenic)全系列产品。


深圳鼎升生物科技有限公司成立于2022年7月29日,坐落在深圳光明区。公司专注于新一代合成生物材料研发及其在新兴生物医药领域中的应用,依托拥有中美自主专利的新型3D可调控高分

子合成生物材料 AccuraMatrix ®技术,实现产品化及市场化。


AcroGenic主营业务基于细胞三维培养和体内外模型平台建立及试剂耗材的生产,治疗性细胞的体外规模化生产及体内植入技术研究及市场化,合成生物平台的建立及合成产品的生产销售。

目前公司已设立北京、深圳和美国的研发及生产中心。


产品范围包括:


(1)AccuraMatrix®细胞外基质

669f4f462ccc2.png

人工合成的有机共聚大分子生物3D架构,能有效模拟细胞生长所需的稳定微环境。

拥有中美自主专利技术,可对架构的孔径大小、结构刚性等理化指标进行调节。


AccuraMatrix可根据培养细胞、细胞球、类器官及组织颗粒的培养需要,通过各类生物材料的不断开发和优化以达到在体外最大限度地模仿体内微环境从而实现多种人类干细胞及原代细胞的体外三维高密度大规模培养、扩增及体内外模型建立。AccuraMatrix细胞外基质产品有普适性强,生物安全性高,可植入性,低成本,高重复性和稳定批次质量。可用于干细胞生产,骨和软骨修复,人造腺体,细胞体内植入。

<<

669f4f9233f1e.jpg



(2)CTC体外培养试剂盒

669f4ff1bd3b2.jpg

肺癌循环肿瘤细胞培养试剂盒

肝癌循环肿瘤细胞培养试剂盒

肾癌循环肿瘤细胞培养试剂盒

胆管癌循环肿瘤细胞培养试剂盒

胰腺癌循环肿瘤细胞培养试剂盒

卵巢癌循环肿瘤细胞培养试剂盒


在AccuraMatrix系统可从外周血中体外培养、增殖,获得足够的数量的CTC,进行全面的分子与功能研究,如对肿瘤细胞与正常细胞物理特性差异的研究;对原发性肿瘤、CTC和转移灶进行基因表达谱的比较;对CTC不同表面标志物表达的研究;对CTC进行药物敏感度实验和建立动物转移模型等。有利于肿瘤患者早期诊断、辅助临床进行精确治疗、术后肿瘤复发与转移及预后评估等。


<

669f50504a604.jpg


应用场景

669f51cd8ec27.png


AccuraMatrixCTC培养可用于肿瘤无创早诊、复发监测、用药指导。细胞外生物材料技术涵盖肿瘤早、中、晚全阶段,早期高危和高度怀疑患者的诊断(液体活检,基因诊断无法确诊),

CTC可以通过对肿瘤细胞的病历诊断做到无创确诊;支持低成本长期培养,可以帮助患者建立起抗药肿瘤模型,并提前筛选出药效药物,指导肿瘤复发治疗,利用CTC培养对治疗效果进

行评估,监测肿瘤复发;晚期病人获得肿瘤样品难, 通过CTC为病人寻找有效药物和药物组合。


另外,AccuraMatrix体外培养扩增后的CTC细胞团可用于动物模型构建,支持肿瘤新药研发、监测肿瘤复发、疗效评估和用药指导。


循环肿瘤细胞体外培养 的基质材料优化及其相关临床应用产品的研发,实现了高成功率循环肿瘤细胞体外培养,建立了世界唯一的循环肿瘤细胞动物体内种植方法,成功地利用循环肿

瘤细胞动物模型进行了体内抗癌药物评估。


目前,AccuraMatrix已完成部分癌种CTC扩增培养和蛋白鉴定。



(3)类器官培养试剂盒


669f521bd23cb.jpg


依托生物基质材料在体外最大限度地模拟体内微环境,实现多种类器官快速构建,并支持类器官与免疫细胞长时间共培养。为抗癌新药研发和患者治疗方案的筛选提供高效、准确、高性价比的服务,为癌症基础研究提供不可或缺的体外 3D 肿瘤模型及动物模型。

<

肺癌类器官培养试剂盒

肝癌类器官培养试剂盒

肾癌类器官培养试剂盒

胆管癌类器官培养试剂盒

胰腺癌类器官培养试剂盒

结直肠癌类器官培养试剂盒

尿道上皮癌类器官培养试剂盒

胃癌类器官培养试剂盒

卵巢癌类器官培养试剂盒

乳腺癌类器官培养试剂盒

恶性体腔积液类器官培养试剂盒

肝癌组织类器官培养试剂盒


微信截图_20240723142714.png

微信截图_20240723142705.png


(4)利用3D培养技术体外生产治疗性蛋白


针对生物合成中存在的某些问题,通过在细胞培养中应用不同的生物材料实现了对细胞培养微环境的调控,改变了细胞状态,实现了多种细胞的共同培养,更换表达细胞种类,从而解决了一定的技术瓶颈

微信截图_20240723142918.png

微信截图_20240723142903.png

" data-original="http://bellbrook.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技授权代理AcroGenic全系列产品">
艾美捷科技授权代理AcroGenic全系列产品
...
阅读详情
Maine Standards.png

艾美捷代理全系列LGC Maine Standards线性校准品。


Maine Standards公司独有的VALIDATE®即用型试剂,可以帮助检验机构对要求的线性、校准和线性范围进行验证。

 

VALIDATE® ready-to-use kits are designed to assist in the documentation of linearity, calibration verification and verification of linear range required by many inspection agencies. VALIDATE® will also provide assistance when troubleshooting instrument systems, reagent problems and calibration anomalies. Multiple product configurations are available to meet the different needs of the many instrument systems available. Configurations are specifically formulated to maximize reportable ranges with minimum dilutions.

产品系列包括:VALIDATE® GC、VALIDATE® PCT、VALIDATE® Body Fluids、VALIDATE® IBC、VALIDATE® LP、VALIDATE® HbA1c、VALIDATE® TDM、VALIDATE® UC、VALIDATE® SP、VALIDATE® THY、VALIDATE® CM、VALIDATE® Anemia、VALIDATE® Fertility、VALIDATE® Tumor Markers、VALIDATE® VIT D、VALIDATE® OSMO、VALIDATE® WBG、VALIDATE® Hemostasis。


64e327dc020ab.png


更多详情请联系 

艾美捷科技有限公司

全国服务热线:400-6800-868

邮箱:sales@amyjet.com

网站:www.amyjet.com


产品列表及详情也可访问艾美捷科技丁香通商城:

https://vicbio.biomart.cn/supply/c_271529.htm






" data-original="http://bellbrook.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理LGC Maine Standards全系列线性校准品">
艾美捷科技代理LGC Maine Standards全系列线性校准品
...
阅读详情
DiscoverX.jpgexocell.jpg

艾美捷科技代理DiscoverX 品牌。

DiscoverX 是一家专注于药物发现和生物分析的公司,提供创新的高通量筛选技术和生物分析工具,支持药物研发、毒理学研究和生物标志物发现。Eurofins DiscoverX® 是值得信赖的药物发现和开发产品解决方案供应商。作为 Eurofins Discovery 的产品部门,以及 Eurofins BioPharma 全球网络的一部分,DiscoverX 在过去二十年里通过为拯救生命的治疗药物的发现和开发做出贡献,这些药物使用了值得信赖和经过验证的细胞基检测产品,用于筛选和验证数十亿个数据点。DiscoverX 产品组合包括适合目的的解决方案,从即用型均质检测试剂盒、稳定的工程细胞系、膜准备、重组蛋白质/酶和合格试剂。


DiscoverX 主要产品和服务包括:

(1)高通量筛选平台:提供基于细胞和酶的高通量筛选平台,用于药物发现和毒性测试。

(2)生物分析工具:提供多种生物分析工具,如报告基因检测、细胞活性检测和蛋白质相互作用分析。

(3)定制服务:根据客户需求,提供定制化的高通量筛选和生物分析服务。

(4)技术咨询与支持:提供药物发现和生物分析相关的咨询和技术支持服务。




< " data-original="http://bellbrook.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理DiscoverX品牌">
艾美捷科技代理DiscoverX品牌
...
阅读详情
66979f745b68d.jpg

艾美捷科技代理LifeSensors品牌。


LifeSensors成立于1996年,位于美国宾夕法尼亚州费城,是一家为药物发现与研究提供方法和可行性技术方法的生物技术公司。公司致力于为泛素和泛素蛋白酶体通路研究领域提供高品质

的抗体、酶、蛋白质等试剂和试剂盒,产品,是泛素研究者的好选择。


其原核和真核蛋白表达系统SUMOpro和SUMOstar已被世界范围内的学术、政府研究机构和制药、生物技术公司广泛应用。通过提供创新的研究工具,LifeSensors已成为泛素和泛素样蛋

白途径的优质供应商。

LifeSensors公司目前主要的产品有400多种,其产品主要覆盖泛素和泛素蛋白酶体通路等科学应用领域,并且产品线在不断的扩大中。公司开创了两大独家技术平台:用于细胞信号和药物

发现的泛素蛋白酶体系统(UPS),以及增强目的蛋白在大肠杆菌、酵母、昆虫和哺乳动物细胞中表达与纯化的SUMO融合表达系统。泛素蛋白酶体系统正在成为继激酶之后,药物发现的下

一个机遇,必将成为未来许多新型药物的创新来源。作为泛素蛋白领域的先驱公司,药物的发现、分析化合物以及去泛素酶和泛素化酶的高通量筛选正是LifeSensors创新技术的真正亮点。

此外,LifeSensors还为泛素的蛋白质组学提供众多定制技术服务,并且已经开发了各种各样的测定细胞中的生理底物或生物标志物的方法。

< " data-original="http://bellbrook.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理LifeSensors品牌">
艾美捷科技代理LifeSensors品牌
...
阅读详情
Megazyme-by-Neogen_Logo.jpgexocell.jpg

<

艾美捷科技代理MegaZyme品牌


Megazyme 成立于1988年,位于爱尔兰,是一家全球知名的酶及酶法分析试剂盒的生产厂家,专注于制造和供应高品质和创新的检测试剂盒和生化分析试剂。Megazyme 产品线以其卓越的高纯度酶制剂而闻名,是全球多种碳水化合物及酶底物产品的核心供应商。该公司目前提供了超过70种诊断试剂盒和超过300种其他试剂和底物。


Megazyme产品广泛应用的领域:

1)食品和饮料‌:用于检测和分析食品中的成分和添加剂。

2)生物燃料‌:用于生物燃料的开发和生产过程中的质量控制。

3)动物饲料‌:确保饲料成分的安全和营养价值。

4)葡萄酒和酿造‌:用于葡萄酒的发酵和质量控制。

5)乳制品和谷类食品‌:用于乳制品和谷类食品的营养成分分析。


正文图.png


Megazyme产品线包括:

● 检测试剂盒:涵盖膳食纤维、淀粉、糖类、醇类、有机酸、酶活性等领域;

● 高纯度酶制剂与生化底物:生产供应种类繁多的高纯度酶,包括:碳水化合物水解酶、氧化还原酶、蛋白酶 & 脂肪酶以及其他特异性酶。此外,Megazyme还提供各种高纯度的酶作用底物,特别是碳水化合物底物;

● 分析标准品与参比物质:提供与检测试剂盒配套或独立的高纯度、认证的分析标准品,包括分析标准缓冲液,辅助因子与染色剂等;

● 配套仪器与自动化解决方案:Megazyme 也开发或整合了部分专用仪器,用于高通量处理特定检测 (如膳食纤维) 中的复杂步骤。


" data-original="http://bellbrook.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理MegaZyme全系列产品">
艾美捷科技代理MegaZyme全系列产品
...
阅读详情
Berry & Associates.png

艾美捷科技代理Berry & Associates全系列修饰核苷酸等


美国 Berry & Associates 公司成立于1989年,提供近200种亚磷酰胺和核苷酸合成用固相交联单体,以及数百种核苷、核苷酸、糖类、荧光标记物、淬灭剂和杂环化合物。

 

Founded in 1989 with roots in the nucleoside field, Berry & Associates soon moved into the chemistry of nucleic acids, resulting in a current portfolio of nearly 200 phosphoramidites and solid phase-linked monomers for oligonucleotide synthesis as well as hundreds of nucleosides, nucleotides, carbohydrates, spacers, fluorescent markers, quenchers, and heterocycles - all proudly made at our facility just outside of Ann Arbor, Michigan. Although our company is small, the credentials of our highly trained staff of chemists include over 400 publications and 80 patents in synthetic organic and medicinal chemistry.  High quality chemicals, timeliness, and personalized service are the hallmarks of Berry & Associates.


Berry & Associates的主要产品包括:

产品名称产品编号纯度规格
2',3'-DideoxyadenosinePR 3495≥95%25 mg; 100 mg
2'-3'-DideoxyguanosinePR 3505≥95%25 mg; 100 mg
2',3'-DideoxyinosinePR 3727≥97%100 mg; 1 g
3'-DeoxythymidinePY 7277≥95%50 mg; 100 mg
2',3'-DideoxyuridinePY 7278≥97%100 mg; 500 mg
2',3'-Didehydro-2',3'-dideoxyuridinePY 7279≥97%25 mg; 100 mg
2',3'-DideoxycytidinePY 7325≥95%50 mg; 100 mg
2-Aminoadenosine (2,6-Diaminopurine riboside)PR 3030≥97%2 g; 10 g
2-Amino-2'-deoxyadenosinePR 3060≥97%1 g; 5 g
2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-deoxyadenosinePR 3080≥95%100 mg; 1 g
2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosinePR 3090≥97%250 mg; 1 g
2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosinePR 3110≥95%250 mg; 1 g
2-Amino-N2-isobutyryl-2'-deoxyadenosinePR 3130≥95%100 mg; 1 g
2-Amino-N2-O-methyladenosinePR 3150≥97%1 g; 10 g
2-(Dimethylaminomethylidene)amino-6-methoxylamino-9-(β-D-2-deoxyribofuranosyl)purinePR 3670≥95%100 mg; 1 g
2-Amino-9-(β-D-2'-deoxyribfuranosyl)purinePR 3070≥97%25 mg; 100 mg
2-Amino-9-(2-O-methyl-β-D-ribofuranosyl)purinePR 3160≥97%100 mg; 250 mg
2-Amino-9-(β-D-ribofuranosy)purine HemihydratePR 3180≥97%25 mg; 100 mg
2-(Dimethylaminomethylidene)amino-9-(β-D-2-deoxyribofuranosyl)purinePR 3680≥97%100 mg; 1 g
6-N-Acyl-6-N-methyl-2'-deoxyadenosinePR 3006≥95%25 mg; 100 mg
8-Amino-2'-deoxyadenosinePR 3115≥97%10 mg; 100 mg
N6-(6-Aminohexyl)-2'-deoxyadenosinePR 3120≥90%100 mg; 1 g
8-Azido-2'-deoxyadenosinePR 3125≥97%10 mg; 100 mg
N6-Benzoyl-8-benzyloxy-2'-deoxyadenosinePR 3230≥95%50 mg; 250 mg
N6-Benzoyl-5'-O-(dimethoxytrityl)-8-oxo-2'-deoxyadenosinePR 3260≥95%100 mg; 1 g
N6-Benzoyl-8-oxo-2'-deoxyadenosinePR 3270≥97%100 mg; 1 g
8-Benzyloxy-2'-deoxyadenosinePR 3280≥97%100 mg; 1 g
8-Bromo-2'-deoxyadenosinePR 3290≥90%2 g; 10 g
8-Bromo-N6-(dimethylaminomethylidene)-2'-deoxyadenosinePR 3320≥95%100 mg; 1 g
8-Bromo-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-2'-deoxyadenosinePR 3340≥97%0g (discontinued);  
2'-Deoxyadenosine MonohydratePR 3445≥97%25 g; 100 g
2',3'-DideoxyadenosinePR 3495≥95%25 mg; 100 mg
2-Fluoro-2'-deoxyadenosinePR 3496≥97%25 mg; 1 g
8-Oxo-2'-deoxyadenosinePR 3705≥95%25 mg; 250 mg
N6-Methyl-2'-deoxyadenosinePR 3740≥97%100 mg; 1 g
4-Chloro-1-(2-deoxy-β-D-ribofuranosyl)-7-methyl-1H-imidazo[4,5-c]pyridinePRA 10012≥95%10 mg; 50 mg
3-Deaza-3-methyl-2'-deoxyadenosinePRA 10013≥97%10 mg; 25 mg
5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosinePRA 10019≥97%500 mg; 1 g
7-(3-Nitrophenyl)-7-deaza-2'-deoxyadenosinePRA 10032≥95%10 mg; 50 mg
5-Iodo-2'-deoxytubercidinPRA 10036≥95%10 mg; 50 mg
8-Allyloxy-2'-deoxyguanosinePR 3010≥90%0Discontinued;  
8-Allyloxy-N2-(dimethylaminomethylidene)-2'-deoxyguanosinePR 3015≥90%1 g; 10 g
8-Allyloxy-N2-isobutyryl-2'-deoxyguanosinePR 3020≥90%1 g; 10 g
5'-Azido-5'-deoxyguanosinePR 3225≥90%5 mg; 10 mg
8-Benzyloxy-N2-isobutyryl-2'-deoxyguanosinePR 3285≥90%1 g; 10 g
8-Bromo-2'-deoxyguanosinePR 3300≥90%1 g; 5 g
8-Bromo-5'-O-(dimethyoxytrityl)-N2-(dimethyl-aminomethylidene)-2'-deoxyguanosinePR 3310≥97%500 mg; 1 g
8-Bromo-N2-(dimethylaminomethylidene)-2'-deoxyguanosinePR 3330≥90%250 mg; 1 g
5'-O-Dimethoxytrityl-N2-(dimethylaminomethylidene)-8-ethenyl-2'-deoxyguanosinePR 3335≥95%100 mg; 1 g
2'-Deoxyguanosine monohydratePR 3452≥97%10 g; 100 g
α-2'-DeoxyguanosinePR 3455≥97%10 mg; 100 mg
2'-DeoxyisoguanosinePR 3465≥97%10 mg; 100 mg
5'-O-(Dimethoxytrityl)-N2-ethyl-2'-deoxyguanosinePR 3600≥97%100 mg; 1 g
3',5'-Di-O-acetyl-2'-deoxyguanosinePR 3605≥97%500 mg; 1 g
5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosinePR 3610≥97%100 mg; 1 g
5'-O-(Dimethoxytrityl)-N2-methyl-2'-deoxy-guanosinePR 3630≥97%100 mg; 1 g
N2-Ethyl-2'-deoxyguanosinePR 3700≥95%25 mg; 100 mg
5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosinePR 3701≥95%25 mg; 100 mg
8-Oxo-2'-deoxyguanosinePR 3710≥97%25 mg; 250 mg
8-Oxo-N2-isobutyryl-2'-deoxyguanosinePR 3720≥90%100 mg; 1 g
N2-Isobutyl-2'-deoxyguanosinePR 3745≥97%10 mg; 100 mg
N1-Methyl-2'-deoxyguanosinePR 3748≥97%25 mg; 1 g
N2-Methyl-2'-deoxyguanosinePR 3750≥97%25 mg; 100 mg
O6-Methyl-2'-deoxyguanosinePR 3755≥90%5 mg; 25 mg
6-Thio-2'-deoxyguanosinePR 3845≥97%10 mg; 100 mg
7-Methyl-7-deaza-2'deoxyguanosinePRA 10042≥97%10 mg; 50 mg
2'-DeoxypseudoguanosinePRA 10103≥97%10 mg; 50 mg
2'-DeoxypseudoisoguanosinePRA 10104≥97%10 mg; 100 mg
8-Aza-7-deaza-2'-deoxyguanosinePRA 10170≥95%10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-onePRA 10175≥95%10 mg; 100 mg
2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosinePR 3090≥97%250 mg; 1 g
2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosinePR 3110≥95%250 mg; 1 g
2-Amino-N2-O-methyladenosinePR 3150≥97%1 g; 10 g
2',3'-Di-O-methyladenosinePR 3540≥97%100 mg; 1 g
5'-O-(Dimethoxytrityl)-2'-O-methylinosinePR 3640≥97%1 g;  
N6-Methyl-2'-O-MethyladenosinePR 3733≥97%50 mg; 100 mg
2'-O-MethyladenosinePR 3734≥97%1 g;  
2'-O-MethylguanosinePR 3760≥97%1 g; 10 g
2'-O-MethylinosinePR 3770≥97%500 mg; 1 g
N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidinePY 7010≥95%0 g DISCONTINUED;  
N4-Acetyl-5'-methyl-2'-O-methylcytidinePY 7020≥97%0 g DISCONTINUED;  
N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidinePY 7100≥95%100 mg; 1 g
N4-Benzoyl-2'-O-methylcytidinePY 7110≥97%500 mg; 1 g
3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridinePY 7290≥95%500 mg; 1 g
3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridinePY 7300≥97%50 mg; 250 mg
3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridinePY 7320≥97%500 mg; 1 g
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidinePY 7350≥97%0     DISCONTINUED;  
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidinePY 7360≥97%0     DISCONTINUED;  
N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidinePY 7370≥97%0     DISCONTINUED;  
5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridinePY 7420≥95%100 mg; 500 mg
5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridinePY 7460≥97%50 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridinePY 7470≥97%100 mg; 1 g
5'-O-(Dimethoxytrityl)-2'-O-methyluridinePY 7480≥97%500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridinePY 7500≥95%25 mg; 100 mg
5-Fluoro-2'-O-methyluridinePY 7570≥97%50 mg; 100 mg
5-Fluoro-2'-O-methyl-4-thiouridinePY 7575≥97%10 mg; 100 mg
5-Fluoro-2'-O-methyl-4-(methylithio)uridinePY 7577≥97%10 mg; 100 mg
5-Iodo-2'-O-methylcytidinePY 7620≥90%20 mg; 100 mg
5-Iodo-2'-O-methyluridinePY 7630≥97%100 mg; 1 g
2'-O-MethylcytidinePY 7636≥97%1 g; 5 g
5-Methyl-2'-O-methylcytidinePY 7640≥97%100 mg; 500 mg
5-Methyl-2'-O-methyluridinePY 7650≥97%100 mg; 1 g
5-(1-Propynyl)-2'-O-methylcytidinePY 7660≥95%10 mg; 50 mg
5-(1-Propynyl)-2'-O-methyluridinePY 7670≥97%10 mg; 25 mg
2'-O-MethyluridinePY 7690≥97%5 g;  
5'-O-Acetyl-3'-azido-N2-palmitoyl-2',3'-dideoxy-guanosinePR 3000≥97%25 mg; 250 mg
3'-Azido-N6-benzoyl-2',3'-dideoxyadenosinePR 3200≥90%50 mg; 250 mg
3'-Azido-2',3'-dideoxyadenosinePR 3210≥97%10 mg; 25 mg
3'-Azido-2',3'-dideoxyguanosinePR 3220≥97%10 mg; 25 mg
3'-Azido-3'-deoxythymidine (AZT)PY 7065≥97%500 mg; 1 g
3'-Azido-3'-deoxy-5'-O-methylthymidinePY 7075≥97%0 g DISCONTINUED;  
3'-Azido-2',3'-dideoxy-5-bromouridinePY 7286≥97%10 mg; 50 mg
N6-Benzoyl-3'-deoxyadenosinePR 3240≥97%100 mg; 1 g
N6-Benzoyl-5'-O-(dimethoxytrityl)-3'-deoxyadenosinePR 3250≥97%100 mg; 1 g
3'-DeoxyadenosinePR 3430≥97%10 mg; 100 mg
3'-DeoxyguanosinePR 3460≥97%10 mg; 100 mg
5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-3'-deoxyguanosinePR 3590≥97%100 mg; 1 g
N2-(Dimethylaminomethylidene)-3'-deoxyguanosinePR 3690≥97%20 mg; 100 mg
2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridinePY 7000≥97%500 mg; 1 g
N4-Benzoyl-3'-deoxycytidinePY 7080≥97%20 mg; 100 mg
3'-DeoxycytidinePY 7220≥97%20 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridinePY 7240≥95%25 mg; 100 mg
5-Methyl-3'-deoxyuridinePY 7260≥95%20 mg; 50 mg
5'-O-(Dimethoxytrityl)-5,6-dihydro-2'-deoxyuridinePY 7230≥97%100 mg;  
5,6-Dihydro-2'-deoxyuridinePY 7330≥97%100 mg;  
(5S)-5,6-DihydrothymidinePY 7340≥97%20 mg; 100 mg
(5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidinePY 7390≥97%100 mg;  
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidinePY 7360≥97%0     DISCONTINUED;  
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidinePY 7400≥97%100 mg; 500 mg
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridinePY 7490≥95%50 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridinePY 7500≥95%25 mg; 100 mg
5-(1-Propynyl)-2'-O-methylcytidinePY 7660≥95%10 mg; 50 mg
5-(1-Propynyl)-2'-O-methyluridinePY 7670≥97%10 mg; 25 mg
5-(1-Propynyl)-2'-deoxycytidinePY 7700≥90%5 mg; 10 mg
5-(1-Propynyl)-2'-deoxyuridinePY 7710≥97%100 mg; 1 g
2-Amino-6-chloro-9-(β-D-2-deoxyribofuranosyl)purinePR 3040≥97%1 g;  
2-Amino-6-chloro-9-(3,5-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purinePR 3045≥95%1 g;  
2-Amino-6-chloro-9-(β-D-ribofuranosyl)purinePR 3050≥95%5 g; 25 g
6-Chloro-9-(β-D-2-deoxyribofuranosyl)purinePR 3370≥97%100 mg; 1 g
6-Chloro-9-(3,5-O-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purinePR 3380≥90%100 mg; 1 g
6-Chloro-9-(5-O-dimethoxytrityl-β-D-2-deoxyribofuranosyl)purinePR 3390≥97%0 g;  
6-Chloro-9-(β-D-ribofuranosyl)purinePR 3400≥97%5 g; 10 g
AdenosinePR 3005≥97%100 g; 1 kg
8-MethyladenosinePR 3007≥95%25 mg; 100 mg
VidarabinePR 3008≥97%1 g; 5 g
2-Aminoadenosine (2,6-Diaminopurine riboside)PR 3030≥97%2 g; 10 g
N1-Methyladenosine hydroiodidePR 3032≥95%100 mg; 1 g
2-MethyladenosinePR 3035≥97%10 mg; 25 mg
5'-Chloro-5'-deoxyadenosinePR 3360≥97%100 mg; 1 g
N6-MethyladenosinePR 3732≥97%100 mg; 1 g
N6-Methyl-2'-O-MethyladenosinePR 3733≥97%50 mg; 100 mg
3-Deaza-3-methyl-2'-deoxyadenosinePRA 10013≥97%10 mg; 25 mg
7-Deazaadenosine (tubercidin)PRA 10035≥97%10 mg; 100 mg
5-Iodo-2'-deoxytubercidinPRA 10036≥95%10 mg; 50 mg
2-Amino-4-chloro-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidinePRA 10000≥97%100 mg; 1 g
2-Amino-4-methoxy-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidinePRA 10005≥97%500 mg; 1 g
4-Chloro-1-(β-D-2-deoxyribofuranosyl)imidazo[4,5-C]pyridinePRA 10006≥90%25 mg; 100 mg
8-AzaadenosinePRA 10007≥97%20 mg;  
8-Aza-7-deaza-2'-deoxyadenosine (4-Amino-1-(2-deoxyribofuranosyl)pyrazolo[3,4-d]-pyrimidine)PRA 10008≥95%10 mg; 100 mg
4-Chloro-1-(3,5-di-O-toluoyl-2-deoxy-β-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidinePRA 10009≥95%100 mg; 1 g
N6-Benzoyl-7-deaza-2'-deoxyadenosinePRA 10010≥97%100 mg; 1 g
Allopurinol ribosidePRA 10011≥97%25 mg; 1 g
5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosinePRA 10019≥97%500 mg; 1 g
N6-Benzoyl-5'-O-(dimethoxytrityl)-7-deaza-2'-deoxyadenosinePRA 10020≥97%100 mg; 1 g
3-Deaza-2'-deoxyadenosinePRA 10025≥97%25 mg; 100 mg
7-Deaza-2'-deoxyadenosinePRA 10030≥97%100 mg; 1 g
7-Deazaadenosine (tubercidin)PRA 10035≥97%10 mg; 100 mg
5-Iodo-2'-deoxytubercidinPRA 10036≥95%10 mg; 50 mg
7-Deaza-2'-deoxyguanosinePRA 10040≥97%100 mg; 1 g
7-DeazaguanosinePRA 10045≥97%10 mg; 100 mg
7-Deaza-2'-deoxyxanthosinePRA 10050≥97%50 mg; 100 mg
5'-O-(Dimethoxytrityl)-7-deaza-2'-deoxyxanthosinePRA 10055≥97%100 mg; 1 g
1-(β-D-2-Deoxyribofuranosyl)-5-nitroindolePRA 10060≥97%100 mg; 1 g
1-(β-D-2-Deoxyribofuranosyl)-4-methylindolePRA 10070≥97%0 g;  
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindolePRA 10080≥97%0 g;  
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindolePRA 10090≥97%100 mg; 1 g
5-IodotubercidinPRA 10095≥90%5 mg; 25 mg
5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-7-deaza-2'-deoxyguanosinePRA 10100≥97%100 mg; 1 g
N2-(Dimethylaminomethylidene)-7-deaza-2'-deoxyguanosinePRA 10110≥97%100 mg; 1 g
SangivamycinPRA 10140≥97%10 mg; 25 mg
ToyocamycinPRA 10150≥97%10 mg; 100 mg
TriciribinePRA 10160≥97%10 mg;  
Tricyclic Nucleoside PhosphatePRA 10162≥95%10 mg;  
8-Aza-7-deaza-2'-deoxyguanosinePRA 10170≥95%10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-onePRA 10175≥95%10 mg; 100 mg
Formycin APYA 11001≥97%10 mg;  
Formycin BPYA 11002≥97%10 mg;  
dNaMFC 8110≥97%25 mg; 100 mg
9-Deaza-2'-deoxyguanosinePRA 10120≥97%10 mg; 100 mg
9-DeazaguanosinePRA 10130≥97%10 mg; 100 mg
2-Chloro-6-(β-D-2-deoxyribofuranosyl)-3,5-diaminopyrazinePYA 11000≥97%10 mg; 25 mg
Formycin APYA 11001≥97%10 mg;  
Formycin BPYA 11002≥97%10 mg;  
PyrazofurinPYA 11004≥97%10 mg;  
2'-DeoxypseudoisocytidinePYA 11005≥97%10 mg; 100 mg
2'-DeoxypseudouridinePYA 11010Purity: ≥97%25 mg; 
5'-O-(Dimethoxytrityl)-N-(dimethylamino)
methylidene-2'-deoxypseudoisocytidine
PYA 11035Purity: ≥97%50 mg; 100 mg
1,3-Dimethyl-2'-deoxypseudouridinePYA 11040≥97%10 mg; 100 mg
1,3-DimethylpseudouridinePYA 11050≥97%10 mg; 50 mg
N1-MethylpseudouridinePYA 11052≥95%10 mg; 50 mg
N3-MethylpseudouridinePYA 11054≥97%10 mg; 25 mg
ShowdomycinPYA 11056≥97%10 mg;  
Pseudoisocytidine hydrochloridePYA 11060≥97%10 mg; 100 mg
PseudothymidinePYA 11070≥97%10 mg; 100 mg
PseudouridinePYA 11080≥97%10 mg; 50 mg
3'-O-(t-Butyldimethylsilyl)-5'-oxo-2'-deoxy-8,5'-cycloadenosinePR 3350≥97%10 mg;  
(5'S)-8,5'-CycloadenosinePR 3410≥97%10 mg; 100 mg
(5'S)-2'-Deoxy-8,5'-cycloadenosinePR 3420≥97%10 mg;  
5'-Deoxy-8,5'-cycloadenosinePR 3440≥97%10 mg; 100 mg
2',5'-Dideoxy-8,5'-cycloadenosinePR 3500≥97%10 mg;  
2',3'-O-Isopropylidene-5'-oxo-8,5'-cycloadenosinePR 3730≥97%10 mg; 100 mg
5'-Oxo-8,5'-cycloadenosinePR 3800≥97%10 mg; 100 mg
5'-Oxo-2'-deoxy-8,5'-cycloadenosinePR 3810≥97%10 mg;  
N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidinePY 7010≥95%0 g DISCONTINUED;  
N4-Acetyl-5'-methyl-2'-O-methylcytidinePY 7020≥97%0 g DISCONTINUED;  
N4-Benzoyl-5-(furan-2-yl)-2'-deoxycytidinePY 7054≥97%25 mg; 100 mg
N4-Benzoyl-3'-deoxycytidinePY 7080≥97%20 mg; 100 mg
N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidinePY 7100≥95%100 mg; 1 g
N4-Benzoyl-2'-O-methylcytidinePY 7110≥97%500 mg; 1 g
5-Bromo-2'-deoxycytidinePY 7115≥97%1 g; 10 g
CytidinePY 7215≥97%50 g; 500 g
2'-DeoxycytidinePY 7216≥97%10 g; 50 g
2'-Deoxycytidine HydrochloridePY 7217≥97%5 g; 50 g
5'-Azido-2',5'-dideoxycytidinePY 7219≥97%25 mg; 100 mg
3'-DeoxycytidinePY 7220≥97%20 mg; 100 mg
N4-Ethyl-2'-deoxycytidinePY 7245≥97%100 mg; 250 mg
5-Methyl-2'-deoxyisocytidinePY 7255≥95%500 mg; 1 g
6-(β-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-onePY 7270≥97%20 mg; 50 mg
2',3'-DideoxycytidinePY 7325≥95%50 mg; 100 mg
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidinePY 7350≥97%0     DISCONTINUED;  
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidinePY 7360≥97%0     DISCONTINUED;  
N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidinePY 7370≥97%0     DISCONTINUED;  
6-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-onePY 7380≥97%50 mg;  
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidinePY 7400≥97%100 mg; 500 mg
5-O-(Dimethoxytrityl)-N4-dimethylaminomethylidene-5-iodo-2'-deoxycytidinePY 7410≥97%100 mg;  
6-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-onePY 7540≥95%250 mg; 500 mg
Cytidin-5-yl-methanesulfonate sodium salt hydratePY 7586≥95%50 mg; 100 mg
5-[(2-Cyanoethoxy)methyl]-2'-deoxycytidinePY 7587≥97%10 mg; 50 mg
5-Hydroxymethyl-2'-deoxycytidinePY 7588≥97%50 mg; 100 mg
5-Formyl-2'-deoxycytidinePY 7589≥97%5 mg; 10 mg
5-Carboethoxy-2'-deoxycytidinePY 7592≥95%25 mg; 100 mg
2'-Deoxycytidine-5-carboxylic acid, sodium saltPY 7593≥95%25 mg; 100 mg
5-Hydroxy-2'-deoxycytidinePY 7595≥95%25 mg; 250 mg
5-HydroxymethylcytidinePY 7596≥97%50 mg; 100 mg
Cytidine-5-carboxylic acid, sodium saltPY 7598≥97%10 mg; 50 mg
5-FormylcytidinePY 7599≥97%5 mg; 10 mg
5-Iodo-2'-deoxycytidinePY 7607≥97%2 g; 10 g
5-IodocytidinePY 7609≥97%5 g;  
5-Iodo-2'-O-methylcytidinePY 7620≥90%20 mg; 100 mg
5-Methyl-2'-deoxycytidine HydrochloridePY 7635≥97%0.25 g; 1 g
2'-O-MethylcytidinePY 7636≥97%1 g; 5 g
5-MethylcytidinePY 7637≥97%1 g; 5 g
N4-MethylcytidinePY 7638≥97%25 mg; 100 mg
5-Methyl-2'-O-methylcytidinePY 7640≥97%100 mg; 500 mg
6-MethylcytidinePY 7641≥97%10 mg; 25 mg
5-(1-Propynyl)-2'-O-methylcytidinePY 7660≥95%10 mg; 50 mg
5-(1-Propynyl)-2'-deoxycytidinePY 7700≥90%5 mg; 10 mg
2-ThiocytidinePY 7721≥97%10 mg; 100 mg
2-Thio-2'-deoxycytidinePY 7723≥95%10 mg; 100 mg
3'-Deoxy-3',4'-didehydrocytidinePY 7790≥95%10 mg; 25 mg
Pyrrolo-dCPYA 11090≥95%10 mg; 100 mg
6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-onePYA 11092≥97%10 mg; 100 mg
3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-onePYA 11095≥95%100 mg; 1 g
3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dionePYA 11100≥95%10 mg; 100 mg
3,N4-Etheno-2'-deoxycytidinePYA 11130≥97%100 mg; 500 mg
N6-Benzoyl-8-oxo-2'-deoxyadenosinePR 3270≥97%100 mg; 1 g
(5'S)-8,5'-CycloadenosinePR 3410≥97%10 mg; 100 mg
(5'S)-2'-Deoxy-8,5'-cycloadenosinePR 3420≥97%10 mg;  
5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosinePR 3610≥97%100 mg; 1 g
8-Oxo-2'-deoxyadenosinePR 3705≥95%25 mg; 250 mg
8-Oxo-2'-deoxyguanosinePR 3710≥97%25 mg; 250 mg
8-Oxo-N2-isobutyryl-2'-deoxyguanosinePR 3720≥90%100 mg; 1 g
8-HydroxyguanosinePR 3795≥97%10 mg; 100 mg
8-Aza-7-deaza-2'-deoxyguanosinePRA 10170≥95%10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-onePRA 10175≥95%10 mg; 100 mg
5-Aza-2'-deoxycytidinePY 7105≥95%25 mg; 100 mg
5,6-Dihydro-5-aza-2'-deoxycytidinePY 7106≥97%25 mg; 100 mg
5,6-Dihydro-2'-deoxyuridinePY 7330≥97%100 mg;  
(5S)-5,6-DihydrothymidinePY 7340≥97%20 mg; 100 mg
5-Hydroxy-2'-deoxycytidinePY 7595≥95%25 mg; 250 mg
5-Hydroxy-2'-deoxyuridinePY 7597≥95%25 mg; 250 mg
5-(2-Hydroxyethyl)-2'-deoxyuridinePY 7600≥95%25 mg; 50 mg
5-Hydroxymethyl-2'-deoxyuridinePY 7605≥95%25 mg; 250 mg
6-MethylcytidinePY 7641≥97%10 mg; 25 mg
Nap-dUPY 7735≥97%10 mg; 25 mg
NPOM-Caged deoxythymidinePY 7795≥97%25 mg; 100 mg
3,N4-Etheno-2'-deoxycytidinePYA 11130≥97%100 mg; 500 mg
Pyrrolo-dCPYA 11090≥95%10 mg; 100 mg
6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-onePYA 11092≥97%10 mg; 100 mg
3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-onePYA 11095≥95%100 mg; 1 g
3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dionePYA 11100≥95%10 mg; 100 mg
8-18O-HydroxyguanosineIOPR 3795≥95%2 mg; 5 mg
2'-DeoxyisoguanosinePR 3465≥97%10 mg; 100 mg
5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosinePR 3701≥95%25 mg; 100 mg
N2-DimethylguanosinePR 3702≥97%10 mg; 100 mg
GuanosinePR 3703≥97%100 g; 500 g
IsoguanosinePR 3735≥97%10 mg; 50 mg
O6-MethylguanosinePR 3757≥97%25 mg; 100 mg
2'-O-MethylguanosinePR 3760≥97%1 g; 10 g
7-Methyl-6-thioguanosinePR 3790≥75%25 mg; 100 mg
8-BromoguanosinePR 3796≥97%0 g;  
8-BenzyloxyguanosinePR 3797≥95%100 mg; 1 g
7-Methyl-7-deaza-2'deoxyguanosinePRA 10042≥97%10 mg; 50 mg
7-DeazaguanosinePRA 10045≥97%10 mg; 100 mg
5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dionePRA 10047≥97%10 mg; 100 mg
2'-DeoxypseudoguanosinePRA 10103≥97%10 mg; 50 mg
2'-DeoxypseudoisoguanosinePRA 10104≥97%10 mg; 100 mg
1-(β-D-2-Deoxyribofuranosyl)-5-nitroindolePRA 10060≥97%100 mg; 1 g
1-(β-D-2-Deoxyribofuranosyl)-4-methylindolePRA 10070≥97%0 g;  
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindolePRA 10080≥97%0 g;  
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindolePRA 10090≥97%100 mg; 1 g
2'-Deoxy-4-desmethylwyosinePR 3450≥95%100 mg; 500 mg
2'-DeoxyinosinePR 3463≥97%10 g; 100 g
5'-Azido-2',5'-dideoxyinosinePR 3464≥97%5 mg; 25 mg
3',5'-Di-O-acetyl-2'-deoxyinosinePR 3480≥97%1 g;  
3',5'-Di-O-acetyl-O6-phenyl-2'-deoxyinosinePR 3490≥90%1 g;  
5'-O-(Dimethoxytrityl)-2'-O-methylinosinePR 3640≥97%1 g;  
5'-O-(Dimethoxytrityl)-O6-phenyl-2'-deoxyinosinePR 3660≥97%100 mg; 1 g
InosinePR 3725≥97%100 g; 500 g
2',3'-DideoxyinosinePR 3727≥97%100 mg; 1 g
2'-O-MethylinosinePR 3770≥97%500 mg; 1 g
7-MethylinosinePR 3780≥95%100 mg; 250 mg
O6-Phenyl-2'-deoxyinosinePR 3840≥97%100 mg; 1 g
2-Fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosinePR 3842≥97%25 mg;  
5'-O-Dimethoxytrityl-2-fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosinePR 3843≥90%25 mg; 100 mg
2'-DeoxyisoguanosinePR 3465≥97%10 mg; 100 mg
N6-(Diisobutylaminomethylidene)-2'-deoxyisoguanosinePR 3510≥90%100 mg; 1 g
N6-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosinePR 3520≥95%100 mg; 1 g
N6-(Diisobutylaminomethylidene)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosinePR 3530≥90%100 mg; 1 g
IsoguanosinePR 3735≥97%10 mg; 50 mg
d5SICSFC 8120≥97%25 mg; 100 mg
AICA Riboside (AICAR)MN 20001≥97%0 g (DISCONTINUED);  
2',3'-Di-O-methyladenosinePR 3540≥97%100 mg; 1 g
2,6-Bis-O-[2-(4-nitrophenyl)ethyl]-2'-deoxyxanthosinePR 3692≥95%10 mg; 100 mg
5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dionePRA 10047≥97%10 mg; 100 mg
8-Aza-7-deaza-2'-deoxyguanosinePRA 10170≥95%10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-onePRA 10175≥95%10 mg; 100 mg
3'-Deoxy-3',4'-didehydrocytidinePY 7790≥95%10 mg; 25 mg
NPOM-Caged deoxythymidinePY 7795≥97%25 mg; 100 mg
tC NucleosidePYA 11110≥97%50 mg; 100 mg
tCnitro NucleosidePYA 11115≥95%5 mg; 25 mg
2'-DeoxynebularinePR 3470

Purity: ≥97%
100 mg; 1 g
7-MethylinosinePR 3780≥95%100 mg; 250 mg
7-Methyl-6-thioguanosinePR 3790≥75%25 mg; 100 mg
1-(β-D-2-Deoxyribofuranosyl)-3-nitropyrrolePYA 11020≥97%50 mg;  
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3-nitropyrrolePYA 11030≥95%100 mg;  
ShowdomycinPYA 11056≥97%10 mg; 
Formycin APYA 11001≥97%10 mg; 
Formycin BPYA 11002≥97%10 mg; 
PseudouridinePYA 11080≥97%10 mg; 
PyrazofurinPYA 11004≥97%10 mg; 
ToyocamycinPRA 10150≥97%10 mg; 
7-Deazaadenosine (tubercidin)PRA 10035≥97%10 mg; 
Allopurinol ribosidePRA 10011≥97%25 mg; 
5-IodotubercidinPRA 10095≥90%5 mg; 
TriciribinePRA 10160≥97%10 mg; 
Tricyclic Nucleoside PhosphatePRA 10162≥95%10 mg; 
5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dionePRA 10047≥97%10 mg; 
5'-Amino-5'-deoxythymidinePY 7030≥97%25 mg; 50 mg
O2,5'-AnhydrothymidinePY 7060≥95%500 mg; 1 g
3'-Azido-3'-deoxythymidine (AZT)PY 7065≥97%500 mg; 1 g
5'-Azido-5'-deoxythymidinePY 7070≥97%25 mg; 100 mg
3'-Azido-3'-deoxy-5'-O-methylthymidinePY 7075≥97%0 g DISCONTINUED;  
3'-O-(t-Butyldimethylsilyl)-5'-deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidinePY 7120≥97%1 g;  
3'-O-(t-Butyldimethylsilyl)thymidinePY 7130≥95%500 mg; 1 g
5'-O-(t-Butyldimethylsilyl)thymidinePY 7140≥97%5 g; 10 g
3',5'-bis-O-(t-Butyldimethylsilyl)thymidinePY 7150≥97%1 g; 5 g
3',5'-bis-O-(t-Butyldimethylsilyl)-O4-(2,4,6-triisopropylphenylsulfonyl)thymidinePY 7160≥95%100 mg; 500 mg
S4-(2-Cyanoethyl)-5'-O-(dimethoxytrityl)-4-thiothymidinePY 7200≥95%10 mg; 100 mg
S4-(2-Cyanoethyl)-4-thiothymidinePY 7210≥95%10 mg; 100 mg
5'-Deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidinePY 7250≥97%1 g;  
3'-DeoxythymidinePY 7277≥95%50 mg; 100 mg
1-(3,5-Di-O-acetyl-β-D-deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)-5-methylpyrmidin-2-onePY 7315≥90%1 g; 10 g
2',3'-Didehydro-3'-deoxythymidinePY 7328≥95%10 mg; 100 mg
(5S)-5,6-DihydrothymidinePY 7340≥97%20 mg; 100 mg
(5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidinePY 7345≥95%10 mg; 25 mg
(5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidinePY 7390≥97%100 mg;  
5'-O-(Dimethoxytrityl)-N3/O4-(toluoyl)-2-thiothymidinePY 7510≥97%50 mg; 100 mg
2-O-EthylthymidinePY 7561≥97%500 mg; 1 g
5'-Iodo-5'-deoxythymidinePY 7610≥97%250 mg; 1 g
5'-O-MethylthymidinePY 7680≥95%50 mg; 100 mg
2-ThiothymidinePY 7725≥95%20 mg; 100 mg
ThymidinePY 7727≥97%25 g; 250 g
5'-O-(p-Toluenesulfonyl)thymidinePY 7740≥97%5 g;  
3-(2-Cyanoethyl)thymidinePY 7742≥95%10 mg; 25 mg
5'-Trifluoroacetamido-5'-deoxythymidinePY 7750≥97%50 mg;  
NPOM-Caged deoxythymidinePY 7795≥97%25 mg; 100 mg
6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-onePYA 11055≥97%5 mg; 25 mg
6-AzathymidinePYA 11058≥95%25 mg; 100 mg
NPOM-Caged-dT CEPBA 0317≥95%100 µmol; 0.25 g
5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridinePY 7040≥97%100 mg; 1 g
5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridinePY 7050≥90%100 mg; 1 g
3'-Azido-3'-deoxy-5'-O-methylthymidinePY 7075≥97%0 g DISCONTINUED;  
(E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridinePY 7170≥97%1 g;  
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridinePY 7180≥97%500 mg; 1 g
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide EsterPY 7190≥97%100 mg; 1 g
(5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidinePY 7345≥95%10 mg; 25 mg
5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridinePY 7520≥97%100 mg; 1 g
5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridinePY 7530≥97%100 mg; 1 g
1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-onePY 7550≥95%100 mg; 1 g
3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridinePY 7560≥95%500 mg; 1 g
5-(2-Hydroxyethyl)-2'-deoxyuridinePY 7600≥95%25 mg; 50 mg
3-(2-Cyanoethyl)thymidinePY 7742≥95%10 mg; 25 mg
5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridinePY 7754≥95%100 mg; 1 g
5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridinePY 7760≥90%100 mg; 1 g
5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridinePY 7770≥95%100 mg; 1 g
NPOM-Caged deoxythymidinePY 7795≥97%25 mg; 100 mg
6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-onePYA 11055≥97%5 mg; 25 mg
5-Ethynyl uridine CEPBA 0353≥90%100 µmol; 0.25 g
2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridinePY 7000≥97%500 mg; 1 g
5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridinePY 7040≥97%100 mg; 1 g
5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridinePY 7050≥90%100 mg; 1 g
5-(Furan-2-yl)-2'-deoxyuridinePY 7053≥97%25 mg; 100 mg
1-(β-D-2-Deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)pyrimidin-2-onePY 7055≥97%20 mg; 100 mg
5-Bromo-2'-deoxyuridinePY 7117≥97%10 g; 25 g
5-BromouridinePY 7118≥95%5 g;  
(E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridinePY 7170≥97%1 g;  
(E)-5-(2-Carbomethoxyvinyl)uridinePY 7172≥97%25 mg; 250 mg
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridinePY 7180≥97%500 mg; 1 g
(E)-5-(2-Carboxyvinyl)uridinePY 7185≥97%1 g;  
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide EsterPY 7190≥97%100 mg; 1 g
S4-(2-Cyanoethyl)-4-thio-2'-deoxyuridinePY 7212≥95%10 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridinePY 7240≥95%25 mg; 100 mg
5-Methyl-3'-deoxyuridinePY 7260≥95%20 mg; 50 mg
2'-DeoxyuridinePY 7275≥97%25 g; 100 g
3',5'-Di-O-acetyl-5-fluoro-2'-deoxyuridinePY 7280≥95%100 mg; 500 mg
3'-Azido-2',3'-dideoxy-5-bromouridinePY 7286≥97%10 mg; 50 mg
3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridinePY 7290≥95%500 mg; 1 g
3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridinePY 7300≥97%50 mg; 250 mg
3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridinePY 7310≥97%20 mg; 50 mg
3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridinePY 7320≥97%500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridinePY 7420≥95%100 mg; 500 mg
5'-O-(Dimethoxytrityl)-5-iodo-2'-deoxyuridinePY 7450≥97%500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridinePY 7460≥97%50 mg; 100 mg
5-Methoxymethyl-2'-deoxyuridinePY 7465≥95%10 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridinePY 7470≥97%100 mg; 1 g
5'-O-(Dimethoxytrityl)-2'-O-methyluridinePY 7480≥97%500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridinePY 7490≥95%50 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridinePY 7500≥95%25 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridinePY 7520≥97%100 mg; 1 g
5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridinePY 7530≥97%100 mg; 1 g
1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-onePY 7550≥95%100 mg; 1 g
3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridinePY 7560≥95%500 mg; 1 g
5-Ethynyl-2'-deoxyuridinePY 7562≥97%25 mg; 100 mg
5-Ethynyl uridinePY 7563≥97%10 mg; 100 mg
5-Fluoro-2'-deoxyuridinePY 7565≥97%100 mg; 1 g
5-Fluoro-2'-O-methyluridinePY 7570≥97%50 mg; 100 mg
5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridinePY 7580≥97%25 mg; 100 mg
5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridinePY 7590≥95%25 mg; 100 mg
5-Hydroxy-2'-deoxyuridinePY 7597≥95%25 mg; 250 mg
5-(2-Hydroxyethyl)-2'-deoxyuridinePY 7600≥95%25 mg; 50 mg
5-Acetoxymethyl-2'-deoxyuridinePY 7604≥97%25 mg; 100 mg
5-Hydroxymethyl-2'-deoxyuridinePY 7605≥95%25 mg; 250 mg
2'-Fluoro-5'-iodo deoxyuridinePY 7612≥95%100 mg;  
5-Iodo-2'-deoxyuridinePY 7615≥97%10 g; 25 g
5-Iodo-2'-O-methyluridinePY 7630≥97%100 mg; 1 g
5-IodouridinePY 7632≥95%5 g; 25 g
5-Methyl-2'-O-methyluridinePY 7650≥97%100 mg; 1 g
5-(1-Propynyl)-2'-O-methyluridinePY 7670≥97%10 mg; 25 mg
2'-O-MethyluridinePY 7690≥97%5 g;  
3-MethyluridinePY 7694≥97%25 mg; 100 mg
5-MethyluridinePY 7695≥97%200 mg; 1 g
5-(1-Propynyl)-2'-deoxyuridinePY 7710≥97%100 mg; 1 g
5-(Propargyloxy)-2'-deoxyuridinePY 7712≥95%10 mg; 100 mg
ZebularinePY 7715≥97%10 mg; 25 mg
3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)-2'-deoxyuridinePY 7720≥90%500 mg; 1 g
2-ThiouridinePY 7724≥97%25 mg; 100 mg
5'-O-(p-Toluenesulfonyl)-2'-deoxyuridinePY 7730≥97%1 g; 5 g
5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridinePY 7754≥95%100 mg; 1 g
5-[3-(Trifluoroacetamido)-1-(E)-propenyl]uridinePY 7758≥97%100 mg; 1 g
5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridinePY 7760≥90%100 mg; 1 g
5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridinePY 7770≥95%100 mg; 1 g
5-[N-(6-(Trifluoracetamido)hexyl)-(E)-acrylamido]uridinePY 7775≥97%100 mg; 1 g
UridinePY 7780≥97%100 g; 500 g
2'3'-O-Isopropylidene uridinePY 7781≥97%5 g; 25 g
5-Hydroxymethyl uridinePY 7782≥97%50 mg; 100 mg
5-MethoxyuridinePY 7783≥97%10 mg; 50 mg
6-Aza-2'-deoxyuridinePYA 11057≥95%50 mg; 100 mg

" data-original="http://bellbrook.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Berry & Associates全系列修饰核苷酸">
艾美捷科技代理Berry & Associates全系列修饰核苷酸
...
阅读详情

城市分站
联系我们

地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301

电话:18771997407

传真:15172469628

邮箱:sales@amyjet.com

0.2669

Copyright © 2026 Powered by BellBrook Labs中国区代理商/公司/官网   鄂ICP备10204150号-10 sitemap